Taho Pharmaceuticals Ltd. (TPEX:6467)
Taiwan
· Delayed Price · Currency is TWD 120.50
+3.00 (2.55%)
At close: Apr 28, 2026
Taho Pharmaceuticals Market Cap
Taho Pharmaceuticals has a market cap or net worth of 6.19 billion as of April 28, 2026. Its market cap has increased by 84.88% in one year.
Market Cap
6.19B
Enterprise Value
5.81B
Revenue
7.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
120.50
Market Cap Chart
Since August 14, 2014, Taho Pharmaceuticals's market cap has increased from 2.09B to 6.19B, an increase of 196.30%. That is a compound annual growth rate of 9.72%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TCM Biotech International | 9.45B |
| Yoda Pharmaceuticals | 3.60B |
| Libo Pharma | 3.07B |
| Pharmasaga | 15.42B |
| Protect Animal Health | 2.19B |
| TEH SENG Pharmaceutical Mfg. | 1.96B |
| TSA International | 1.93B |
| Gin Hwa Biotech Incorporation | 1.81B |